Company intelligence / Profile preview

Asuragen

Austin, Texas, United Statesasuragen.com ↗

Ownership: Private
Employees: ~124
Development stage: Commercial

Overview

Asuragen has commercialized FDA-cleared molecular diagnostic kits such as the AmplideX® Fragile X Diagnostic and Carrier Screening kit and Quantidex® qPCR IS BCR/ABL kit. The company continues to expand its pipeline with new genetic panels for carrier screening in collaboration with partners like Oxford Nanopore Technologies. Its products are widely adopted in clinical laboratories globally.

Therapeutic areas: OncologyRare DiseasesWomen's Health
Modalities: PCR-based diagnostic kits (Polymerase chain reaction)qPCR-based diagnostic kits (Quantitative polymerase chain reaction)Capillary electrophoresis-based assaysNext-generation sequencing-based assaysDiagnostic software solutions
Industry: Molecular Diagnostics

Drug pipeline

2 assets

AmplideX Fragile X Diagnostic Kit

Commercial

Indications: Fragile X Syndrome

1 more asset in the full pipeline.

Request access →

Partnerships

Oxford Nanopore Technologies (for expanded genetic panel development)

Beyond the preview

Go deeper on Asuragen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asuragen.

Explore the full profile